Pdt Partners, LLC Pacira Bio Sciences, Inc. Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

A detailed history of Pdt Partners, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 230,477 shares of PCRX stock, worth $3.77 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

230,477

Holding current value

$3.77 Million

% of portfolio

0.34%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $2.7 Million - $6.56 Million	230,477 New	230,477 $3.47 Million
Q3 2023 Nov 14, 2023	SELL	$30.68 - $40.09 $22,212 - $29,025	-724 Reduced 1.61%	44,229 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $108 - $142	3 Added 0.01%	44,953 $1.8 Million
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $1.6 Million - $1.95 Million	44,950 New	44,950 $1.83 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $611,281 - $792,742	-12,743 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $5,464 - $6,130	-100 Reduced 0.78%	12,743 $714,000
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $760,048 - $898,881	12,843 New	12,843 $779,000
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $3.62 Million - $4.39 Million	-69,713 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $1.07 Million - $1.83 Million	-34,787 Reduced 33.29%	69,713 $3.66 Million
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $988,320 - $1.76 Million	34,800 Added 49.93%	104,500 $3.5 Million
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $2,188 - $2,530	-60 Reduced 0.09%	69,700 $2.65 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $2,230 - $2,816	54 Added 0.08%	69,760 $3 Million
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $1 Million - $1.59 Million	-30,494 Reduced 30.43%	69,706 $3.43 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $2.76 Million - $3.99 Million	100,200 New	100,200 $3.21 Million

Others Institutions Holding PCRX

# of Institutions

266

Shares Held

50.6M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $750M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account